Dr. Altice is board-certified in both Infectious Diseases and Addiction Medicine. His research interests are focused on the interface between infectious diseases including HIV, tuberculosis, and viral hepatitis, and substance use disorders. He has been at the forefront of integrating medication-assisted therapies such as methadone, buprenorphine, and extended-release naltrexone into managing co-morbid conditions. In recent years, he has increasingly become involved in implementation science to find improved ways to disseminate research and ensure that evidence-based practices are implemented using best-practices.